Engineers Gate Manager’s Filana Therapeutics FLNA Stock Holding History

Engineers Gate Manager’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.7K	Sell	31,663 -7,831	-20%	-$11.2K	﹤0.01%	2145
2026 Q1	$66.7K	Buy	39,494 +7,840	+25%	+$16.1K	﹤0.01%	2068
2025 Q4	$62.7K	Buy	31,654 +17,335	+121%	+$55.5K	﹤0.01%	1959
2025 Q3	$41.7K	Buy	+14,319	New	+$32.9K	﹤0.01%	2070
2025 Q1	–	Sell	-48,058	Closed	-$113K	–	2523
2024 Q4	$113K	Buy	+48,058	New	+$844K	﹤0.01%	1981
2024 Q1	–	Sell	-37,249	Closed	-$838K	–	2255
2023 Q4	$838K	Buy	+37,249	New	+$787K	0.02%	897
2023 Q2	–	Sell	-13,689	Closed	-$330K	–	1994
2023 Q1	$330K	Buy	+13,689	New	+$379K	0.01%	1194
2022 Q1	–	Sell	-7,532	Closed	-$329K	–	2258
2021 Q4	$329K	Buy	+7,532	New	+$395K	0.01%	1336
2021 Q2	–	Sell	-15,420	Closed	-$693K	–	1969
2021 Q1	$693K	Buy	+15,420	New	+$606K	0.03%	797

Other funds holding FLNA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Engineers Gate Manager's FLNA Position: Q2 2026 in Review

Engineers Gate Manager reduced its Filana Therapeutics (FLNA) stake by 20% in Q2 2026, selling an estimated $11.2K and leaving 31,663 shares worth $37.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2145.

Engineers Gate Manager first reported a position in FLNA in Q1 2021 and has held it in 9 quarters since. The position peaked at $838K in Q4 2023. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

Engineers Gate Manager held 31,663 shares of Filana Therapeutics worth $37.7K as of Q2 2026.
Engineers Gate Manager sold 7,831 Filana Therapeutics shares in Q2 2026, an estimated $11.2K.
Filana Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2145 holding.
Engineers Gate Manager first reported a position in Filana Therapeutics in Q1 2021 and has held it in 9 quarters since.
Engineers Gate Manager's Filana Therapeutics position peaked at $838K in Q4 2023.
85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.